Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Schiedam"'
Autor:
Braal CL; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Westenberg JD; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Lommen KMWT; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Vastbinder MB; Department of Internal Medicine, IJsselland Hospital, Capelle aan den IJssel, The Netherlands., van Rossum-Schornagel QC; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands., Thijs-Visser MF; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands.; Department of Internal Medicine, Spijkenisse MC, Spijkenisse, The Netherlands., van Alphen RJ; Department of Internal Medicine, Elisabeth Tweesteden Hospital, Tilburg, The Netherlands., Struik LEM; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Zuetenhorst HJM; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. s.koolen@erasmusmc.nl.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. s.koolen@erasmusmc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Apr; Vol. 61 (4), pp. 527-537. Date of Electronic Publication: 2021 Nov 17.
Autor:
Hussaarts KGAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, PO Box 2040, 3015, GD, Rotterdam, The Netherlands. g.hussaarts@erasmusmc.nl., Berger FA; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands., Binkhorst L; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Hospital Pharmacy, HAGA Hospital, Den Haag, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, PO Box 2040, 3015, GD, Rotterdam, The Netherlands., van Leeuwen RWF; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands., van Alphen RJ; Department of Internal Medicine, Elisabeth-Tweesteden hospital, Tilburg, the Netherlands., Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Vlietland & Gasthuis, Schiedam, the Netherlands., de Groot NMS; Department of Cardiology, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, PO Box 2040, 3015, GD, Rotterdam, The Netherlands., van Gelder T; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Pharmaceutical research [Pharm Res] 2019 Dec 16; Vol. 37 (1), pp. 7. Date of Electronic Publication: 2019 Dec 16.
Autor:
Binkhorst L; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. l.binkhorst@erasmusmc.nl.; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands. l.binkhorst@erasmusmc.nl., Bannink M; Department of Psychiatry, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Ruit J; Department of Internal Medicine, Vlietland Hospital, Schiedam, The Netherlands., Droogendijk H; Department of Internal Medicine, Franciscus Hospital, Roosendaal, The Netherlands., van Alphen RJ; Department of Internal Medicine, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands., den Boer TD; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Lam MH; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., van Gelder T; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2016 Feb; Vol. 55 (2), pp. 249-55.